3591 related articles for article (PubMed ID: 10676951)
1. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
Alizadeh AA; Eisen MB; Davis RE; Ma C; Lossos IS; Rosenwald A; Boldrick JC; Sabet H; Tran T; Yu X; Powell JI; Yang L; Marti GE; Moore T; Hudson J; Lu L; Lewis DB; Tibshirani R; Sherlock G; Chan WC; Greiner TC; Weisenburger DD; Armitage JO; Warnke R; Levy R; Wilson W; Grever MR; Byrd JC; Botstein D; Brown PO; Staudt LM
Nature; 2000 Feb; 403(6769):503-11. PubMed ID: 10676951
[TBL] [Abstract][Full Text] [Related]
2. B-cell differentiation, apoptosis and proliferation in diffuse large B-cell lymphomas.
Bai M; Skyrlas A; Agnantis NJ; Kamina S; Papoudou-Bai A; Kitsoulis P; Kanavaros P
Anticancer Res; 2005; 25(1A):347-62. PubMed ID: 15816558
[TBL] [Abstract][Full Text] [Related]
3. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.
Wright G; Tan B; Rosenwald A; Hurt EH; Wiestner A; Staudt LM
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9991-6. PubMed ID: 12900505
[TBL] [Abstract][Full Text] [Related]
4. A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines.
Culpin RE; Proctor SJ; Angus B; Crosier S; Anderson JJ; Mainou-Fowler T
Int J Oncol; 2010 Aug; 37(2):367-76. PubMed ID: 20596664
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
6. The biology of human lymphoid malignancies revealed by gene expression profiling.
Staudt LM; Dave S
Adv Immunol; 2005; 87():163-208. PubMed ID: 16102574
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of diffuse large B-cell lymphoma.
Rosenwald A; Staudt LM
Leuk Lymphoma; 2003; 44 Suppl 3():S41-7. PubMed ID: 15202524
[TBL] [Abstract][Full Text] [Related]
8. DNA microarrays in lymphoid malignancies.
Rosenwald A
Oncology (Williston Park); 2003 Dec; 17(12):1743-8; discussion 1750, 1755, 1758-9 passim. PubMed ID: 14723013
[TBL] [Abstract][Full Text] [Related]
9. Clinical translation of gene expression profiling in lymphomas and leukemias.
Rosenwald A; Staudt LM
Semin Oncol; 2002 Jun; 29(3):258-63. PubMed ID: 12063678
[TBL] [Abstract][Full Text] [Related]
10. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells.
Davis RE; Brown KD; Siebenlist U; Staudt LM
J Exp Med; 2001 Dec; 194(12):1861-74. PubMed ID: 11748286
[TBL] [Abstract][Full Text] [Related]
11. Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas.
Lu X; Nechushtan H; Ding F; Rosado MF; Singal R; Alizadeh AA; Lossos IS
Blood; 2005 Apr; 105(7):2924-32. PubMed ID: 15591113
[TBL] [Abstract][Full Text] [Related]
12. Diffuse large B-cell lymphoma.
Li S; Young KH; Medeiros LJ
Pathology; 2018 Jan; 50(1):74-87. PubMed ID: 29167021
[TBL] [Abstract][Full Text] [Related]
13. Diffuse large B-cell lymphoma: insights gained from gene expression profiling.
Lossos IS; Levy R
Int J Hematol; 2003 May; 77(4):321-9. PubMed ID: 12774918
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical classification of de novo, transformed, and relapsed diffuse large B-cell lymphoma into germinal center B-cell and nongerminal center B-cell subtypes correlates with gene expression profile and patient survival.
Haarer CF; Roberts RA; Frutiger YM; Grogan TM; Rimsza LM
Arch Pathol Lab Med; 2006 Dec; 130(12):1819-24. PubMed ID: 17149956
[TBL] [Abstract][Full Text] [Related]
15. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.
Rosenwald A; Wright G; Leroy K; Yu X; Gaulard P; Gascoyne RD; Chan WC; Zhao T; Haioun C; Greiner TC; Weisenburger DD; Lynch JC; Vose J; Armitage JO; Smeland EB; Kvaloy S; Holte H; Delabie J; Campo E; Montserrat E; Lopez-Guillermo A; Ott G; Muller-Hermelink HK; Connors JM; Braziel R; Grogan TM; Fisher RI; Miller TP; LeBlanc M; Chiorazzi M; Zhao H; Yang L; Powell J; Wilson WH; Jaffe ES; Simon R; Klausner RD; Staudt LM
J Exp Med; 2003 Sep; 198(6):851-62. PubMed ID: 12975453
[TBL] [Abstract][Full Text] [Related]
16. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity.
Lossos IS; Levy R; Alizadeh AA
Leukemia; 2004 Nov; 18(11):1775-9. PubMed ID: 15385936
[TBL] [Abstract][Full Text] [Related]
17. UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma.
Bedekovics T; Hussain S; Feldman AL; Galardy PJ
Blood; 2016 Mar; 127(12):1564-74. PubMed ID: 26702068
[TBL] [Abstract][Full Text] [Related]
18. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.
Iqbal J; Sanger WG; Horsman DE; Rosenwald A; Pickering DL; Dave B; Dave S; Xiao L; Cao K; Zhu Q; Sherman S; Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Ott G; Müller-Hermelink HK; Delabie J; Braziel RM; Jaffe ES; Campo E; Lynch JC; Connors JM; Vose JM; Armitage JO; Grogan TM; Staudt LM; Chan WC
Am J Pathol; 2004 Jul; 165(1):159-66. PubMed ID: 15215171
[TBL] [Abstract][Full Text] [Related]
19. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction.
Bea S; Zettl A; Wright G; Salaverria I; Jehn P; Moreno V; Burek C; Ott G; Puig X; Yang L; Lopez-Guillermo A; Chan WC; Greiner TC; Weisenburger DD; Armitage JO; Gascoyne RD; Connors JM; Grogan TM; Braziel R; Fisher RI; Smeland EB; Kvaloy S; Holte H; Delabie J; Simon R; Powell J; Wilson WH; Jaffe ES; Montserrat E; Muller-Hermelink HK; Staudt LM; Campo E; Rosenwald A;
Blood; 2005 Nov; 106(9):3183-90. PubMed ID: 16046532
[TBL] [Abstract][Full Text] [Related]
20. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
